InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+15.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Goodman Vicki L, Directrice Générale du Développement de Produits. Insider active across 2 companies, notably Exelixis, INC.. In total, 9 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €74k. Activity tracked since 4 January 2022. The latest transaction was disclosed on 10 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Goodman Vicki L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
84,727 sharesOrdinary SharesSEC:0001193125-25-308745:0
5,036 shares@ US$2.0812.3% of flowOrdinary SharesSEC:0001193125-25-274765:0
35,000 shares0Ordinary SharesSEC:0000950170-25-033764:0
13,186 shares@ US$3.8975.7% of flowOrdinary SharesSEC:0000950170-25-026609:0
5,069 shares@ US$3.3324.3% of flowOrdinary SharesSEC:0000950170-24-124041:0
73,018 shares0Ordinary SharesSEC:0000950170-23-071113:0
82,566 shares0Common StockSEC:0000939767-23-000037:0
17,299 shares@ US$18.08100.0% of flowCommon StockSEC:0000939767-23-000022:0
250,000 shares0Common StockSEC:0000939767-22-000004:0
9 of 9 declarations
About Goodman Vicki L
Vicki L. Goodman is the EVP of Product Development & Medical Affairs & CMO at EXELIXIS, INC. She oversees product development and medical affairs, ensuring that initiatives align with business objectives. Her role is crucial in strengthening the company's position in the market.
